title: Effect of requiring advance approval of chemotherapy on number and cost of ungiven doses.
authors.forename: Malik
authors.initials: M
authors.lastname: Berhoune
authors.forename: Haïl
authors.initials: H
authors.lastname: Aboudagga
authors.forename: Aude
authors.initials: A
authors.lastname: Jacob
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Grandhaye
authors.forename: Corinne
authors.initials: C
authors.lastname: Dayot
authors.forename: Patrice
authors.initials: P
authors.lastname: Prognon
authors.forename: Brigitte
authors.initials: B
authors.lastname: Bonan
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000191:economics*; D003365:Costs and Cost Analysis; D004339:Drug Compounding / Q000191:economics* / Q000592:standards; D005602:France; D006801:Humans; D010607:Pharmacy Service, Hospital / Q000191:economics* / Q000331:legislation & jurisprudence* / Q000592:standards
chemical_list: D000970:Antineoplastic Agents